Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
07/2006
07/13/2006US20060156422 Methods and compositions for the generation of antibodies
07/13/2006US20060156421 High throughput screening methods for anti-metastatic compounds
07/13/2006US20060156420 Malarial animal model having a chimeric human liver
07/13/2006US20060156419 Mouse model for autoimmune disorders
07/13/2006US20060154339 Novel clock gene BMAL2
07/13/2006US20060153826 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
07/13/2006CA2596783A1 Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor
07/13/2006CA2592870A1 Development and use of a new orthotopic genetically tractable non-human animal model for liver cancer
07/13/2006CA2588026A1 Methods and compositions for rna interference
07/13/2006CA2563656A1 Enriched pag-55 fraction and methods for early detection of pregnancy in ungulate animals
07/12/2006EP1678298A2 Expression of dominant negative transmembrane receptors in the milk of transgenic animals
07/12/2006EP1678205A1 Clq RELATED PROTEIN
07/12/2006EP1677606A2 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
07/12/2006EP1590663A4 Immunocompromised rodents as dual color tumor models
07/12/2006EP1196583B1 Type ii dna polymerase from pyrococcus abyssi
07/12/2006EP0870045B1 Gene control
07/12/2006CN1802566A Screen for pre-eclampsia
07/12/2006CN1799349A Substrate-free breeding method for pharmaceutical ground beetle
07/12/2006CN1263850C Method for breeding transgenic zebra fish and its special plasmid
07/12/2006CN1263376C Natural scorpion-breeding simulated method
07/12/2006CN1263375C Breeding method of black-shin yellow chicken
07/12/2006CN1263374C Method for setting up dioecism type mussel inbred line
07/11/2006US7074983 Trangenic cell for use in human therapeutics and diagnostics
07/11/2006US7074614 Clock gene BMAL2
07/11/2006CA2335387C Method for analyzing phyletic lineage of scallop
07/06/2006WO2006071435A2 Methods for correcting mitotic spindle defects and optimizing preimplantation embryonic developmental rates associated with somatic cell nuclear transfer in animals
07/06/2006WO2006070718A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs
07/06/2006WO2006048466A3 Animal models comprising at least one conditional ko and one conditional ki
07/06/2006WO2006048464A3 Expressing heterologous genes in a specific manner in certain tissues of transgenic animal models
07/06/2006WO2006040594A3 Nek kinase (nima related kinase) proteins
07/06/2006WO2006003215A3 Targeted transgenesis of short hairpin rna expression cassettes using recombinase mediated cassette exchange
07/06/2006WO2005062881A3 Gene therapy using transposon-based vectors
07/06/2006US20060150271 Artificial chromosomes, uses thereof and method for preparing artificial chromosomes
07/06/2006US20060150267 Methods of using testis-specific insulin homolog polypeptides
07/06/2006US20060150266 TRP6 calcium channel disruptions, compositions and methods related thereto
07/06/2006US20060150265 Transgenic mice containing sulfotransferase gene disruptions
07/06/2006US20060150264 Differential gene expression in schizophrenia
07/06/2006US20060150263 Novel enzymes and metabolites involved in skatole metabolism
07/06/2006US20060150262 Novel mucin-like polypeptides
07/06/2006US20060150261 Intracellular antibodies for a retrovirus protein
07/06/2006US20060150260 Genes related to drug resistance
07/06/2006US20060150259 Model of bone disease amenable to high-throughput screening
07/06/2006US20060148378 Artificial diets for honey bees
07/06/2006US20060147937 Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences
07/06/2006US20060147933 Interspecies embryonic stem cell
07/06/2006US20060147377 tumor cell line, reponsive to histone deacetylase inhibitors, transfected with vector containing reporter gene such as fluorescent protein, linked to promotor that also controls expression of protein associated with tumor regression, stabilization of tumor growth or inhibition of metastatic growth
07/06/2006CA2592461A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs
07/06/2006CA2592282A1 Phytoseiid mite rearing methods and methods for biological pest control
07/06/2006CA2591599A1 Method for producing polyunsaturated long-chain fatty acids in transgenic organisms
07/05/2006EP1676920A2 Anticoagulant fusion protein anchored to cell membrane
07/05/2006EP1676916A1 Hamster EF-1Alpha transcriptional regulatory DNA
07/05/2006EP1435774A4 Enhanced resolution of tumor metastasis
07/05/2006EP1399575B1 Methods of modifying eukaryotic cells
07/05/2006EP1280404B1 Model for neurodegenerative disease
07/05/2006EP1187938A4 Method of transposon-mediated mutagenesis in the nematode caenorhabditis elegans
07/05/2006EP1096955B9 Uses of antibodies to aminophospholipids for cancer treatment
07/05/2006EP0972445B1 Chimeric mice that express a human antibody
07/05/2006CN1796556A Control of gene expression
07/05/2006CN1262650C Tissue cement proteins from rhipicephalus appendiculatus
07/05/2006CN1262175C Method of livestock sex discriminated birth and treating agent, frozen sperm and filling device
07/04/2006US7071373 introducing cultures of pluripotent cells into embryos having genetic complement comprising nucleotide sequence that code proteins; genetic engineering; xenografts
07/04/2006US7071372 Method for cloning animals with targetted genetic alterations by transfer of long-term cultured male or female somatic cell nuclei, comprising artificially-induced genetic alterations, to enucleated recipient cells
07/04/2006US7071323 Anxiolytic agents; psychological disorders; insertion of genetic vector into nucleic acids, transcription
07/04/2006US7071305 Human transport protein; brain and kidney analysis; animal models; drug screening; nephrotoxicity; removal of toxic anions from circulatory system
07/04/2006US7070994 genetic engineered retrovirus; from transgenic animals; drug transport
07/04/2006US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering
07/04/2006US7070970 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid
06/2006
06/29/2006WO2006069306A2 A knockout mouse for the tumor suppressor gene anx7
06/29/2006WO2006068326A1 Novel polypeptide and the use thereof
06/29/2006WO2006067913A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited
06/29/2006WO2006067847A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited
06/29/2006WO2006067356A1 Method for obtaining a sea bass triploid interspecific triploid hybrid
06/29/2006WO2006066334A1 Potassium channels in human heart
06/29/2006WO2006054326A3 Animal model for studying substances with cardiotherapeutic and anti-hypertensive activity
06/29/2006WO2006037327A3 Polypeptides having phytase activity and polynucleotides encoding same
06/29/2006WO2006017293A3 Models and methods for nociception, pain transduction, and screening for analgesic compounds
06/29/2006WO2005118790A3 Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins
06/29/2006WO2005095652A3 Pnmt as a novel marker for progenitor cells
06/29/2006WO2004044125A3 Vesicle-associated proteins
06/29/2006US20060143725 Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained
06/29/2006US20060143724 Transgenic mice containing anaphylatoxin C3a gene disruptions
06/29/2006US20060143723 Use of glucose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
06/29/2006US20060143722 OGR1 gene disruptions, compositions and methods relating thereto
06/29/2006US20060143721 Transgenic mice containing tryptase gene disruptions
06/29/2006US20060143720 Transgenic mice containing chordin gene disruptions
06/29/2006US20060143719 Use of golden hamster as infectivity model of SARS
06/29/2006US20060143718 Transgenic animals for monitoring water quality
06/29/2006US20060142547 Anktm1, a cold-activated trp-like channel expressed in nociceptive neurons
06/29/2006US20060142196 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases
06/29/2006US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals
06/29/2006US20060141545 Cancer treatment kits using antibodies to aminophospholipids
06/29/2006US20060141463 Method of detecting bone paget's disease
06/29/2006US20060140945 Nephropathy-associated gene
06/29/2006US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation
06/29/2006CA2592201A1 Neuromedin s and the use thereof
06/28/2006EP1673438A2 Transgenic rodents selectively expressing human b1 bradykinin receptor protein
06/28/2006EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon
06/28/2006EP1212429B1 Luciferase expression cassettes and methods of use
06/28/2006EP0990041B1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor
06/28/2006CN1794908A Method for cloning in the rat by nuclear transfer